No Picture
Trading Ideas

Hedge Funds Getting Back In Momo Inc (MOMO)

“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). This appears to be the longest and most severe drought for value […] …read more […]

No Picture
Trading Ideas

Don’t Use a Market Order for Options Trading

Many investors are sabotaging their retirements unnecessarily – and for the life of me, I can’t figure out why.
One thing I will never understand about the market is why there should even be an option to place market orders on everyday trades. These orders get investors into more trouble than any other strategy when buying or selling stocks.
A market order allows you to buy a stock or option at the price it’s trading when your order is received. That might not hurt for a stock trading with penny spreads if the market isn’t moving fast.
But for Long-Term Equity Anticipation Securities …read more […]

No Picture
Trading Ideas

Hedge Funds Are Undecided About The Goodyear Tire & Rubber Company (GT)

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […] …read more […]

No Picture
Trading Ideas

Hedge Funds Are Warming Up To GlaxoSmithKline plc (GSK)

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […] …read more […]

No Picture
Business News

Trump upbeat on U.S.-China talks as Beijing underscores tariff-cut demands

U.S.-China trade talks are “moving right along,” President Donald Trump said on Thursday, striking an upbeat tone even as Chinese officials held fast to their line that existing tariffs must come off as part of an interim deal to de-escalate the 17-month trade war between the two powers.

…read more […]

No Picture
Trading Ideas

UPDATE 1-Televisa wins injunction over Disney purchase of Fox assets in Mexico

Mexican broadcaster Grupo Televisa has won a federal injunction against Walt Disney Co’s acquisition of Twenty-First Century Fox Inc’s assets in Mexico, a Televisa representative said on Thursday, a move that could at least temporarily stall the deal. “We are very pleased that the federal judiciary has ordered a full review of the merger in light of the arguments we presented almost a year ago,” Televisa said in a statement to Reuters. Disney closed its $71 billion purchase of Fox’s film and television assets in March, marking one of the largest media deals in recent history after Disney …read more […]

No Picture
Business News

BlackRock says global active equities chief Wiseman to leave firm after breaching relationships policy

Mark Wiseman, global head of active equities at BlackRock Inc, is leaving the firm following a violation of the company’s “relationships at work policy,” the world’s largest asset manager said in an internal memo on Thursday.

…read more […]

No Picture
Trading Ideas

Hedge Funds Welcomed Peloton Interactive, Inc. (PTON) With Open Arms

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third quarter. You can find articles about an individual hedge fund’s trades on numerous financial […] …read more […]

No Picture
Trading Ideas

Wild Biotech Day Sparks $7.6 Billion Shuffle for Neurology Trio

(Bloomberg) — Thursday marked another wild day for biotechnology firms as a highly-anticipated presentation from Biogen Inc. took the spotlight and results from neurology-focused peers triggered huge stock swings amid a flurry of reports.When the dust settled in afternoon trading, the presentation from Biogen, combined with key study data from Sage Therapeutics Inc. and Acadia Pharmaceuticals Inc., resulted in a combined $7.6 billion shift in value for the three companies. The huge moves were yet another reminder of how biotechnology investing — and, more specifically, betting on drug development for diseases affecting the brain — can often resemble a roulette …read more […]